Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,680,839
  • Shares Outstanding, K 155,922
  • Annual Sales, $ 58,440 K
  • Annual Income, $ -80,740 K
  • EBIT $ -114 M
  • EBITDA $ -111 M
  • 60-Month Beta 1.26
  • Price/Sales 29.19
  • Price/Cash Flow N/A
  • Price/Book 4.33

Options Overview Details

View History
  • Implied Volatility 74.48% ( +3.88%)
  • Historical Volatility 56.68%
  • IV Percentile 10%
  • IV Rank 12.35%
  • IV High 359.40% on 11/13/23
  • IV Low 34.35% on 06/11/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 174
  • Volume Avg (30-Day) 506
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 18,112
  • Open Int (30-Day) 15,611

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.23
  • Number of Estimates 6
  • High Estimate -0.21
  • Low Estimate -0.30
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +54.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.93 +20.72%
on 10/10/24
11.77 -8.45%
on 10/28/24
+1.30 (+13.71%)
since 10/07/24
3-Month
7.85 +37.32%
on 08/14/24
11.77 -8.45%
on 10/28/24
+2.41 (+28.79%)
since 08/07/24
52-Week
2.00 +440.35%
on 11/10/23
11.77 -8.45%
on 10/28/24
+7.94 (+279.58%)
since 11/07/23

Most Recent Stories

More News
Ocular Therapeutixâ„¢ to Report Third Quarter 2024 Results on November 14, 2024

OCUL : 10.78 (-1.46%)
Ocular Therapeutixâ„¢ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLIâ„¢ in Wet AMD

OCUL : 10.78 (-1.46%)
Ocular Therapeutixâ„¢ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OCUL : 10.78 (-1.46%)
Ocular Therapeutixâ„¢ to Present at October Ophthalmology Meetings

OCUL : 10.78 (-1.46%)
Ocular Therapeutix: Q2 Earnings Snapshot

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 10.78 (-1.46%)
3 Standout Stocks Under $10 With 86% Upside Potential or More

As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.

AMZN : 210.05 (+1.43%)
AAPL : 227.48 (+2.14%)
NVDA : 148.88 (+2.25%)
OPAL : 3.85 (unch)
OCUL : 10.78 (-1.46%)
NUVB : 2.62 (+3.15%)
Ocular Therapeutix: Q1 Earnings Snapshot

Ocular Therapeutix: Q1 Earnings Snapshot

OCUL : 10.78 (-1.46%)
2 Small-Cap Growth Stocks With Room To Run

These two small-cap growth stocks could be ready to run.

REGN : 824.48 (+0.96%)
RHHBY : 38.1700 (+1.06%)
ACHR : 3.50 (+9.03%)
OCUL : 10.78 (-1.46%)
Ocular Therapeutix: Q4 Earnings Snapshot

Ocular Therapeutix: Q4 Earnings Snapshot

OCUL : 10.78 (-1.46%)
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

BIIB : 173.92 (-0.28%)
XBI : 103.01 (+0.56%)
XLK : 237.42 (+1.74%)
OCUL : 10.78 (-1.46%)
LRMR : 9.12 (+11.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 11.60
2nd Resistance Point 11.33
1st Resistance Point 11.06
Last Price 10.78
1st Support Level 10.52
2nd Support Level 10.25
3rd Support Level 9.98

See More

52-Week High 11.77
Last Price 10.78
Fibonacci 61.8% 8.04
Fibonacci 50% 6.88
Fibonacci 38.2% 5.73
52-Week Low 2.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar